Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method of tadalafil intermediate

A technology of tryptophan and hydrochloride, which is applied in the direction of organic chemistry, can solve the problems of cumbersome post-processing, violent reaction, and high cost, and achieve the effects of improving stereoselectivity, simple post-processing, and reducing risks

Active Publication Date: 2015-04-29
SUNSHINE LAKE PHARM CO LTD
View PDF1 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Among them, D-tryptophan methyl ester hydrochloride is prepared by refluxing D-tryptophan and thionyl chloride in methanol. This method reacts violently and uses a large amount of thionyl chloride, which is highly corrosive and has potential safety hazards. , and the post-processing is cumbersome, MTBE (methyl tert-butyl ether) will be used, the smell is large, the cost is high, and the yield is low

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of tadalafil intermediate
  • Preparation method of tadalafil intermediate
  • Preparation method of tadalafil intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1D

[0026] The preparation of embodiment 1D-tryptophan methyl ester hydrochloride

[0027] Add D-tryptophan (50g) to a mixed solution of toluene (650ml) and methanol (105ml) and stir evenly, slowly add thionyl chloride (38.6g) dropwise at 0°C, and heat up to 75 After reflux reaction at ~80°C for 4 hours, the reaction is over, the reaction solution is cooled to 0°C and stirred for 2 hours, the solid precipitates, filtered, the filter cake is washed with toluene, and vacuum-dried at 50°C for 6h to obtain D-tryptophan methyl Ester hydrochloride, white powder solid. Yield 95%, HPLC purity 99%.

Embodiment 2

[0028] The preparation method of embodiment 2 compound (II)

[0029]

[0030] Into the reaction bottle, add quantitative D-tryptophan methyl ester hydrochloride (50g), compound (IV) (32.5g), acetonitrile (500ml), stir evenly, heat up to 75-85°C, reflux for 16h, HPLC detects that the reaction is progressing; after the reaction, cool down to 25±5°C, stir and crystallize for 4h; filter with suction, wash the filter cake with a small amount of acetonitrile, and dry it in vacuum at 50°C for 6-8h to obtain a white solid with a yield of 94.2%, the compound The HPLC purity of (II) was 98.175%, and the enantiomeric excess (ee%) was 99.12%.

Embodiment 3

[0031] Embodiment 3HPLC detection condition

[0032] 1. The analysis methods of central control and intermediates are as follows:

[0033]

[0034]

[0035] 2. Compound (II) chiral isomer analysis method:

[0036] Chromatographic column: CHIRAL PAK AS-H (4.6*250mm, 5μm);

[0037] Mobile phase: n-hexane-ethanol (containing 0.1% DEA) = 40:60 (on-line mixing);

[0038] Flow rate: 0.5ml / min; Column temperature: 30°C; Wavelength: 225nm.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an improved method of preparing a compound (II). The improved method comprises the following steps: (the formula is shown in the description) 1, mixing D-tryptophan, methanol and toluene, adding thionyl chloride dropwise, and then carrying out reaction at the temperature of 70-85 DEG C to obtain D-tryptophan ester hydrochloride, wherein the structure is shown in a formula (III):(the formula is shown in the specification); and 2, mixing the D-tryptophan ester hydrochloride, a compound (IV) and a nitrile solvent, uniformly stirring, then raising the temperature to 75-85 DEG C, and carrying out reaction, (the formula is shown in the description). The improved preparation method of the compound shown by the D-tryptophan ester hydrochloride (II) has the following beneficial effects: 1, the dosage of the thionyl chloride in the first step is greatly reduced, so that the risk and the corrosion of the reaction are lowered, the post-processing is simple, and the yield is above 90 percent; 2, in the second step, the nitrile solvent is adopted to improve the stereoselectivity, and the enantiomer extra amount (ee %) is above 99 percent.

Description

technical field [0001] The invention relates to the field of medicinal chemistry, in particular to an improved preparation method of tadalafil intermediate D-tryptophan methyl ester hydrochloride. Background technique [0002] Tadalafil, also known as (6R-12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexa Hydrogenated pyrazino[1',2'-1,6]-pyrido[3,4-b]indole-1,4-dione, compound represented by formula (I), trade name "Cialis", is an oral PDE5 inhibitor for erectile dysfunction (ED). Tadalafil was launched in the U.S. in December 2003 as a once-a-day oral dosage form. It is also approved in the United States and Europe for benign prostatic hyperplasia and pulmonary hypertension. [0003] [0004] US Patent No. 5,859,006 for the first time discloses a method for preparing tadalafil by the following route. [0005] [0006] Among them, D-tryptophan methyl ester hydrochloride is prepared by refluxing D-tryptophan and thionyl chloride in methanol. This method rea...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D471/04C07D209/20
CPCC07D209/20C07D471/04
Inventor 黄凯赵吉业李宇熙刘浏
Owner SUNSHINE LAKE PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com